Rhythm Biosciences Requests Trading Halt
Key points
- Company requests trading halt pending announcement on proposed underwriting agreement
- Halt to remain in place until expected announcement or market open on 25 February 2026
- No other information known that would require disclosure
Full summary
Rhythm Biosciences Ltd has requested a trading halt in its securities (ASX: RHY) pending the release of an announcement related to a proposed underwriting agreement for the company's outstanding RHYO options. The trading halt will remain in place until the earlier of the expected announcement being made or the market opening on Wednesday, 25 February 2026. The company stated that it is not aware of any other reason why the trading halt request should not be granted or of any other information that needs to be disclosed to the market at this time.
Summary generated by a large language model. Please interpret with care.